About Corey Goodman
Form D filings for NFlection Therapeutics from 2017 to 2023 list Corey Goodman as director.
Corey Goodman first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Corey Goodman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Corey Goodman works with at each company, as listed on that company's latest Form D.
NFlection Therapeutics, Inc. · Form D, Jul 21, 2023
KP
Ketan Patel
Director
CP
Christopher Powala
Director
WH
William Hodder
President and Director
JG
Josh Grass
Director